NASDAQ:TCRX | Profit Breakdown | TScan Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-06-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$1.05M-$30.49M-$30.36M
2026-03-31$982,000.00-$29.14M-$28.67M
2025-12-31$2.57M-$23.86M-$22.98M
2025-09-30$2.51M-$37.05M-$35.71M
2025-06-30$3.08M-$38.65M-$36.95M
2025-03-31$2.17M-$36.25M-$34.13M
2024-12-31$665,000.00-$36.71M-$35.81M
2024-09-30$1.05M-$32.62M-$29.89M
2024-06-30$536,000.00-$34.11M-$31.66M
2024-03-31$566,000.00-$31.37M-$30.14M
2023-12-31$7.21M-$21.36M-$19.61M
2023-09-30$3.89M-$24.75M-$23M
2023-06-30$3.15M-$24.61M-$24.05M
2023-03-31$6.8M-$22.74M-$22.56M
2022-12-31$3.1M-$18.65M-$18.72M
2022-09-30$3.36M-$16.58M-$16.25M
2022-06-30$4.06M-$15.25M-$15.1M
2022-03-31$3.02M-$16.16M-$16.16M
2021-12-31$2.85M-$14.2M-$14.2M
2021-09-30$2.41M-$15.84M-$15.84M
2021-06-30$2.85M-$10.68M-$10.67M
2021-03-31$2.03M-$7.92M-$7.91M
2020-12-31$795,000.00-$7.81M-$7.81M
2020-09-30$290,000.00-$7.17M-$7.17M
2020-06-30-$5.62M-$5.61M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$10.33M-$135.81M-$129.77M
2024-12-31$2.82M-$134.82M-$127.5M
2023-12-31$21.05M-$93.46M-$89.22M
2022-12-31$13.54M-$66.64M-$66.22M
2021-12-31$10.14M-$48.64M-$48.63M
2020-12-31$1.09M-$26.23M-$26.13M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.